Summit Investment Advisory Services LLC Decreases Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Summit Investment Advisory Services LLC cut its stake in ARK Genomic Revolution ETF (BATS:ARKGFree Report) by 6.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,251 shares of the company’s stock after selling 1,025 shares during the period. Summit Investment Advisory Services LLC’s holdings in ARK Genomic Revolution ETF were worth $359,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of ARKG. National Bank of Canada FI raised its stake in shares of ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after purchasing an additional 920 shares during the last quarter. IHT Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $203,000. Sanctuary Advisors LLC acquired a new stake in ARK Genomic Revolution ETF during the 2nd quarter valued at approximately $222,000. Hilltop Holdings Inc. purchased a new stake in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at $237,000. Finally, Dynamic Advisor Solutions LLC increased its stake in shares of ARK Genomic Revolution ETF by 7.8% in the third quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after acquiring an additional 989 shares during the period.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG stock opened at $27.09 on Friday. The firm’s fifty day moving average is $24.89 and its 200 day moving average is $25.14.

About ARK Genomic Revolution ETF

(Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

Recommended Stories

Institutional Ownership by Quarter for ARK Genomic Revolution ETF (BATS:ARKG)

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.